Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
Robert E. Schoen(University of Pittsburgh Medical Center), Christine D. Berg(Prevention Group), Robert S. Bresalier(The University of Texas MD Anderson Cancer Center), Mark P. Purdue(Government of the United States of America), E. David Crawford(University of California San Diego), Philip C. Prorok(National Cancer Institute), Danielle M. Carrick(National Institutes of Health), John K. Gohagan(National Institutes of Health), Timothy R. Church(University of Minnesota), Paul F. Pinsky(National Cancer Institute), Anthony B. Miller(University of Toronto), Christine Cole Johnson(Henry Ford Health System), Joel L. Weissfeld(University of Pittsburgh), Patrick Wright(Information Management Services), Claudine Isaacs(Georgetown University), Saundra S. Buys(University of Utah), Mona N. Fouad(University of North Texas), Lance Yokochi(National Institutes of Health), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Adeyinka O. Laiyemo(Howard University), Douglas J. Reding(Ascension), Barnett S. Kramer(University of Pittsburgh), Barbara O’Brien(National Institutes of Health), Thomas L. Riley(Automation, Information, and Management Systems (United States)), Grant Izmirlian(National Institutes of Health)
Cited by 1,027
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k